These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28349656)

  • 1. Equine performance genes and the future of doping in horseracing.
    Wilkin T; Baoutina A; Hamilton N
    Drug Test Anal; 2017 Sep; 9(9):1456-1471. PubMed ID: 28349656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene doping.
    Harridge SD; Velloso CP
    Essays Biochem; 2008; 44():125-38. PubMed ID: 18384287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing strategies for detection of gene doping.
    Baoutina A; Alexander IE; Rasko JE; Emslie KR
    J Gene Med; 2008 Jan; 10(1):3-20. PubMed ID: 18081214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control analyses in horseracing: a clinician's guide.
    Wong JK; Wan TS
    Vet J; 2014 Apr; 200(1):8-16. PubMed ID: 24485918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control.
    Tozaki T; Ohnuma A; Kikuchi M; Ishige T; Kakoi H; Hirota KI; Kusano K; Nagata SI
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32340130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping control study of AICAR in post-race urine and plasma samples from horses.
    Wong JKY; Kwok WH; Chan GHM; Choi TLS; Ho ENM; Jaubert M; Bailly-Chouriberry L; Bonnaire Y; Cawley A; Ming Williams H; Keledjian J; Brooks L; Chambers A; Lin Y; Wan TSM
    Drug Test Anal; 2017 Sep; 9(9):1363-1371. PubMed ID: 28407446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in detecting substances for equine anti-doping.
    Fragkaki AG; Kioukia-Fougia N; Kiousi P; Kioussi M; Tsivou M
    Drug Test Anal; 2017 Sep; 9(9):1291-1303. PubMed ID: 28087984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene doping: possibilities and practicalities.
    Wells DJ
    Med Sport Sci; 2009; 54():166-175. PubMed ID: 19696514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of designer anabolic steroids in equine sports.
    Waller CC; McLeod MD
    Drug Test Anal; 2017 Sep; 9(9):1304-1319. PubMed ID: 27732767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene doping: of mice and men.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2009 Apr; 42(6):435-41. PubMed ID: 19272337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of genes for performance enhancement: doping or therapy?
    Oliveira RS; Collares TF; Smith KR; Collares TV; Seixas FK
    Braz J Med Biol Res; 2011 Dec; 44(12):1194-201. PubMed ID: 22030863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration and detection of gene therapy in horses: A systematic review.
    Haughan J; Ortved KF; Robinson MA
    Drug Test Anal; 2023 Feb; 15(2):143-162. PubMed ID: 36269665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of anabolic steroids and their relevance to drug detection in horseracing.
    Teale P; Houghton E
    Bioanalysis; 2010 Jun; 2(6):1085-107. PubMed ID: 21083210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligence-based anti-doping from an equine biological passport.
    Cawley AT; Keledjian J
    Drug Test Anal; 2017 Sep; 9(9):1441-1447. PubMed ID: 28266147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene doping: an overview and current implications for athletes.
    van der Gronde T; de Hon O; Haisma HJ; Pieters T
    Br J Sports Med; 2013 Jul; 47(11):670-8. PubMed ID: 23322893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically transformed world records: a reality or in the sphere of fantasy?
    Gatzidou E; Gatzidou G; Theocharis SE
    Med Sci Monit; 2009 Feb; 15(2):RA41-47. PubMed ID: 19179981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene doping in sports.
    Unal M; Ozer Unal D
    Sports Med; 2004; 34(6):357-62. PubMed ID: 15157120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of secondary biomarker of met-eGH as a strategy to screen for somatotropin misuse in horseracing.
    Bailly-Chouriberry L; Chu-Van E; Pinel G; Garcia P; Popot MA; André-Fontaine G; Bonnaire Y; Le Bizec B
    Analyst; 2008 Feb; 133(2):270-6. PubMed ID: 18227952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.